| Primary |
| Colorectal Cancer Metastatic |
22.9% |
| Colon Cancer |
11.6% |
| Product Used For Unknown Indication |
11.4% |
| Colon Cancer Metastatic |
7.0% |
| Pancreatic Carcinoma |
6.4% |
| Brain Stem Glioma |
5.2% |
| Adenocarcinoma Of Colon |
4.1% |
| Chemotherapy |
4.1% |
| Alveolar Rhabdomyosarcoma |
3.5% |
| Premedication |
3.5% |
| Rectal Cancer |
3.5% |
| Prophylaxis Of Nausea And Vomiting |
3.3% |
| Metastases To Liver |
2.3% |
| Colon Neoplasm |
1.9% |
| Colorectal Cancer |
1.9% |
| Lung Neoplasm Malignant |
1.9% |
| Analgesic Therapy |
1.7% |
| Rhabdomyosarcoma |
1.4% |
| Diabetes Mellitus |
1.2% |
| Hodgkin's Disease Stage Iii |
1.2% |
|
| Vomiting |
18.4% |
| Toxicity To Various Agents |
7.1% |
| Weight Decreased |
7.1% |
| Neutropenia |
6.1% |
| Pyrexia |
6.1% |
| Malaise |
5.1% |
| Paraesthesia |
5.1% |
| Pulmonary Embolism |
5.1% |
| Thrombocytopenia |
5.1% |
| Tremor |
5.1% |
| Neuropathy Peripheral |
4.1% |
| Pancreatitis Acute |
4.1% |
| Diarrhoea |
3.1% |
| Oedema Mouth |
3.1% |
| Papule |
3.1% |
| Tumour Haemorrhage |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Atrial Fibrillation |
2.0% |
| Cerebrovascular Accident |
2.0% |
| Deep Vein Thrombosis |
2.0% |
|
| Secondary |
| Colorectal Cancer Metastatic |
37.9% |
| Colorectal Cancer |
18.2% |
| Colon Cancer |
7.8% |
| Colon Cancer Metastatic |
5.0% |
| Product Used For Unknown Indication |
4.6% |
| Drug Use For Unknown Indication |
3.3% |
| Rectal Cancer |
2.5% |
| Neoplasm |
2.3% |
| Prophylaxis |
2.0% |
| Pancreatic Carcinoma |
2.0% |
| Hypertension |
1.8% |
| Glioblastoma |
1.6% |
| Gastric Cancer |
1.6% |
| Chemotherapy |
1.6% |
| Pancreatic Carcinoma Metastatic |
1.5% |
| Medulloblastoma |
1.5% |
| Nausea |
1.3% |
| Adenocarcinoma |
1.3% |
| Metastases To Liver |
1.3% |
| Premedication |
1.1% |
|
| Vomiting |
17.4% |
| Disease Progression |
15.0% |
| Neutropenia |
9.1% |
| Thrombocytopenia |
6.3% |
| Diarrhoea |
5.5% |
| Sepsis |
4.7% |
| Pyrexia |
4.5% |
| Febrile Neutropenia |
4.4% |
| Death |
4.0% |
| Stomatitis |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Intestinal Obstruction |
3.3% |
| Pulmonary Embolism |
3.2% |
| Toxicity To Various Agents |
2.9% |
| Weight Decreased |
2.7% |
| Rash |
2.5% |
| General Physical Health Deterioration |
2.1% |
| Malignant Neoplasm Progression |
1.8% |
| Nausea |
1.8% |
| Thrombosis |
1.8% |
|
| Concomitant |
| Colon Cancer |
17.1% |
| Colorectal Cancer Metastatic |
15.2% |
| Colorectal Cancer |
12.5% |
| Colon Cancer Metastatic |
8.9% |
| Rectal Cancer |
7.2% |
| Product Used For Unknown Indication |
6.3% |
| Premedication |
4.4% |
| Metastases To Liver |
4.0% |
| Drug Use For Unknown Indication |
3.8% |
| Adenocarcinoma Of Colon |
2.8% |
| Metastases To Lung |
2.7% |
| Rectal Cancer Metastatic |
2.4% |
| Metastatic Neoplasm |
2.3% |
| Rhabdomyosarcoma |
1.9% |
| Sarcoma |
1.7% |
| Hypertension |
1.6% |
| Glioblastoma |
1.5% |
| Pain |
1.4% |
| Chemotherapy |
1.2% |
| Glioblastoma Multiforme |
1.1% |
|
| Disease Progression |
23.8% |
| Death |
16.4% |
| Vomiting |
14.1% |
| Weight Decreased |
4.8% |
| Pyrexia |
3.7% |
| Neoplasm Malignant |
3.3% |
| Rash |
3.3% |
| Throat Irritation |
3.3% |
| Sepsis |
3.0% |
| Stomatitis |
3.0% |
| Diarrhoea |
2.6% |
| Thrombocytopenia |
2.6% |
| White Blood Cell Count Decreased |
2.6% |
| Haemorrhage |
2.2% |
| Hyperammonaemic Encephalopathy |
1.9% |
| Infusion Related Reaction |
1.9% |
| Intestinal Obstruction |
1.9% |
| Malignant Neoplasm Progression |
1.9% |
| Neutropenia |
1.9% |
| Pruritus |
1.9% |
|
